Docetero RTU Injection (Docetaxel Injection IP 80 mg)

Docetero RTU Injection is a branded oncology injectable formulation containing docetaxel, a well-established taxane-class antineoplastic agent. Manufactured using Ready-to-Use (RTU) technology, this formulation is designed to support standardized preparation practices within regulated oncology environments. Docetero RTU Injection with Docetaxel Injection IP 80 mg is supplied by AmeriDrugs for export-oriented pharmaceutical distribution to licensed importers, hospitals, pharmacies, and oncology-focused distributors.

Active Ingredient (API + Strength)

• Active Pharmaceutical Ingredient: Docetaxel IP

• Strength: 80 mg per 4 ml

• Dosage Form: Sterile injectable solution

Therapeutic Use (Informational, Non-Advisory)
Docetaxel is a semi-synthetic taxane used in approved oncology treatment frameworks for various solid tumors. Docetero RTU Injection is utilized within institutional and regulated healthcare settings as part of established chemotherapy protocols determined by local regulatory approvals and clinical guidelines. This information is provided solely for product identification and compliance purposes and does not constitute medical advice.

Dosage Form & Route of Administration

• Dosage Form: Ready-to-use injectable solution

• Route of Administration: Intravenous infusion after dilution

• Prescription Status: Prescription-only medicine

• Intended for professional handling within regulated pharmaceutical and oncology settings

Quality & Manufacturing Standards
Docetero RTU Injection is manufactured in accordance with current Good Manufacturing Practices (GMP) and relevant pharmacopeial standards. RTU formulation technology supports consistency, sterility assurance, and stability across batches. Each lot undergoes comprehensive quality control testing to meet international export and regulatory requirements.

Packaging Information (Export-Oriented)

• Primary Packaging: Glass vial containing 4 ml sterile solution

• Secondary Packaging: Printed carton with regulatory-compliant labeling

• Packaging designed for oncology supply chains and international logistics

• Export documentation and labeling support available based on destination market regulations

Target Buyers

• Licensed pharmaceutical importers and distributors

• Oncology hospitals and cancer treatment centers

• Retail and wholesale pharmacies operating under prescription regulations

• Government and private institutional procurement agencies

• International distributors specializing in oncology injectables

Regulatory & Compliance Note
Docetero RTU Injection is a prescription-only oncology medicine intended for regulated pharmaceutical distribution. Not for direct consumer self-use. Product supply is subject to import authorization, local drug regulatory approvals, and institutional procurement policies in the destination country. AmeriDrugs follows international export compliance standards and supports regulatory documentation requirements.